{
  "locale": "en",
  "category": "mental_health",
  "generatedAt": "2025-12-27T03:34:57.576Z",
  "count": 12,
  "diseases": [
    {
      "id": "depressao",
      "titulo": "Major Depressive Disorder",
      "sinonimos": [
        "Depression",
        "Major Depression",
        "Depressive Episode"
      ],
      "doid": "DOID:1470",
      "snomedCT": "35489007",
      "meshId": "D003865",
      "umlsCui": "C0011570",
      "ciap2": [
        "P76"
      ],
      "cid10": [
        "F32",
        "F33"
      ],
      "categoria": "mental_health",
      "quickView": {
        "definicao": "A mental disorder characterized by persistent depressed mood and/or loss of interest for ≥2 weeks, accompanied by cognitive, behavioral, and physical symptoms, causing significant functional impairment.",
        "criteriosDiagnosticos": [
          "≥5 symptoms for ≥2 weeks, with either depressed mood OR anhedonia being mandatory",
          "Others: weight/appetite changes, insomnia/hypersomnia, agitation/retardation",
          "Fatigue, feelings of worthlessness/guilt, concentration difficulties",
          "Thoughts of death or suicidal ideation",
          "Significant functional impairment (work, relationships, self-care)"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Psychoeducation about the disease and treatment",
            "Psychotherapy (Cognitive Behavioral Therapy, interpersonal therapy) - recommended for all",
            "Regular physical activity (antidepressant effect)",
            "Sleep hygiene",
            "Social and family support",
            "Abstinence from alcohol and drugs"
          ],
          "farmacologico": [
            "SSRIs first line: Fluoxetine 20-60mg, Sertraline 50-200mg, Escitalopram 10-20mg",
            "SNRIs: Venlafaxine 75-225mg, Duloxetine 60-120mg (if associated pain)",
            "Tricyclic: Amitriptyline 25-150mg (if pain, insomnia, low cost)",
            "Minimum 6-12 months after remission. Maintenance if ≥3 episodes"
          ]
        },
        "metasTerapeuticas": [
          "Complete remission of symptoms (PHQ-9 <5)",
          "Return to previous functioning",
          "Prevention of relapses",
          "Identification and management of comorbidities"
        ],
        "examesIniciais": [
          "TSH (to rule out hypothyroidism)",
          "Complete blood count (anemia)",
          "Blood glucose",
          "Renal and liver function (baseline for medications)",
          "Vitamin B12 and folic acid (if elderly or malnourished)"
        ],
        "redFlags": [
          "Structured suicidal ideation with plan and intent",
          "Recent prior suicide attempt",
          "Psychotic symptoms (delusions, hallucinations)",
          "Manic or hypomanic episode (suggests bipolarity)",
          "Catatonia",
          "Risk of heteroaggression"
        ]
      },
      "fullContent": {
        "epidemiologia": {
          "prevalencia": "7-10% of the adult population, 2x more common in women",
          "incidencia": "Peak at 25-44 years",
          "mortalidade": "Suicide: 15% in severe untreated cases",
          "fatoresRisco": [
            "Family history of depression",
            "Adverse childhood events",
            "Chronic stress, grief, unemployment",
            "Chronic diseases (DM, chronic pain, cancer)",
            "Substance use",
            "Prior anxiety disorder",
            "Postpartum period"
          ],
          "citations": [
            {
              "refId": "who-depression-2023"
            }
          ]
        },
        "quadroClinico": {
          "sintomasPrincipais": [
            "Depressed mood most of the day",
            "Anhedonia (loss of pleasure)",
            "Weight/appetite changes (increase or decrease)",
            "Insomnia or hypersomnia",
            "Fatigue, loss of energy",
            "Feelings of worthlessness or excessive guilt",
            "Concentration difficulties",
            "Thoughts of death, suicidal ideation"
          ],
          "sinaisExameFisico": [
            "Neglected appearance",
            "Psychomotor retardation or agitation",
            "Sad facial expression, crying",
            "Slow, monotonous speech",
            "Difficulty maintaining eye contact"
          ],
          "formasClinicas": [
            "Mild: minimal symptoms, preserved functionality",
            "Moderate: evident symptoms and functional impairment",
            "Severe: intense symptoms, risk of suicide, possible psychosis"
          ],
          "citations": [
            {
              "refId": "dsm-5"
            }
          ]
        },
        "diagnostico": {
          "criterios": [
            "≥5 symptoms for ≥2 weeks (depressed mood or anhedonia mandatory)",
            "Significant clinical impairment",
            "Not attributable to substance or medical condition",
            "No prior manic or hypomanic episode"
          ],
          "diagnosticoDiferencial": [
            "Bipolar disorder",
            "Hypothyroidism",
            "Anemia",
            "Adjustment disorder",
            "Normal grief",
            "Secondary depression (medications, diseases)"
          ],
          "examesLaboratoriais": [
            "TSH, complete blood count, blood glucose, renal and liver function",
            "Vitamin B12, folate (elderly)",
            "Toxicology screen if substance use is suspected"
          ],
          "citations": [
            {
              "refId": "dsm-5"
            }
          ]
        },
        "tratamento": {
          "objetivos": [
            "Remission of symptoms",
            "Functional recovery",
            "Prevention of relapses and recurrences",
            "Improvement in quality of life"
          ],
          "naoFarmacologico": {
            "medidas": [
              "Psychotherapy: CBT (12-20 sessions) or interpersonal therapy",
              "Behavioral activation",
              "Physical exercise: 30-45 min, 3-5x/week",
              "Sleep hygiene",
              "Support groups",
              "Mindfulness"
            ],
            "citations": [
              {
                "refId": "nice-depression-2022"
              }
            ]
          },
          "farmacologico": {
            "primeiraLinha": [
              {
                "classe": "SSRIs",
                "medicamentos": [
                  "Fluoxetine 20-60mg/day",
                  "Sertraline 50-200mg/day",
                  "Escitalopram 10-20mg/day"
                ],
                "posologia": "Once daily, in the morning",
                "observacoes": "Start with a low dose, increase every 2 weeks. Effect in 2-4 weeks"
              }
            ],
            "segundaLinha": [
              {
                "classe": "SNRIs",
                "medicamentos": [
                  "Venlafaxine 75-225mg/day",
                  "Duloxetine 60-120mg/day"
                ],
                "observacoes": "If associated chronic pain or SSRI failure"
              },
              {
                "classe": "Tricyclic",
                "medicamentos": [
                  "Amitriptyline 25-150mg/day",
                  "Nortriptyline 25-150mg/day"
                ],
                "observacoes": "Lower cost. More adverse effects. Pre-treatment ECG if >40 years"
              },
              {
                "classe": "Others",
                "medicamentos": [
                  "Bupropion 150-300mg/day",
                  "Mirtazapine 15-45mg/day"
                ],
                "observacoes": "Bupropion: smoking cessation. Mirtazapine: insomnia, anorexia"
              }
            ],
            "situacoesEspeciais": [
              {
                "situacao": "Pregnancy",
                "conduta": "Sertraline is safer. Avoid paroxetine in the 1st trimester"
              },
              {
                "situacao": "Elderly",
                "conduta": "Start with lower doses. Prefer SSRIs"
              },
              {
                "situacao": "Bipolarity",
                "conduta": "Antidepressant + mood stabilizer. Refer to psychiatry"
              }
            ],
            "citations": [
              {
                "refId": "nice-depression-2022"
              }
            ]
          },
          "duracao": "Minimum 6-12 months after remission. Indefinite maintenance if ≥3 episodes or risk factors"
        },
        "acompanhamento": {
          "frequenciaConsultas": "Weekly/biweekly initially, then monthly, quarterly when stable",
          "examesControle": [
            "PHQ-9 at each visit",
            "Assessment of adverse effects",
            "Assessment of suicide risk",
            "ECG if tricyclic in >40 years"
          ],
          "metasTerapeuticas": [
            "PHQ-9 <5 (remission)",
            "Return to work/activities",
            "Normalized sleep and appetite",
            "Absence of suicidal ideation"
          ],
          "criteriosEncaminhamento": [
            "High suicide risk",
            "Psychotic symptoms",
            "Suspected bipolarity",
            "Treatment-resistant (failure of 2+ antidepressants)",
            "Need for ECT",
            "Severe psychiatric comorbidity"
          ],
          "citations": [
            {
              "refId": "nice-depression-2022"
            }
          ]
        }
      },
      "protocolos": [
        "protocolo-depressao"
      ],
      "medicamentos": [
        "fluoxetina",
        "sertralina",
        "amitriptilina",
        "escitalopram"
      ],
      "calculadoras": [
        "phq9",
        "phq2"
      ],
      "citations": [
        {
          "refId": "dsm-5"
        },
        {
          "refId": "nice-depression-2022"
        }
      ],
      "lastUpdate": "2024-12",
      "tags": [
        "mental_health",
        "chronic",
        "prevalent"
      ]
    },
    {
      "id": "transtorno-ansiedade-generalizada",
      "titulo": "Generalized Anxiety Disorder (GAD)",
      "categoria": "mental_health",
      "cid10": [
        "F41.1"
      ],
      "cid11": [
        "6B00"
      ],
      "ciap2": [
        "P74"
      ],
      "snomedCT": "21897009",
      "doid": "DOID:14320",
      "meshId": "D001008",
      "umlsCui": "C0270458",
      "dsm5": {
        "code": "300.02",
        "category": "Anxiety Disorders",
        "diagnosticCriteria": {
          "code": "300.02",
          "name": "Generalized Anxiety Disorder",
          "category": "Anxiety Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at least 6 months, about various events or activities"
            },
            {
              "letter": "B",
              "text": "The individual finds it difficult to control the worry"
            },
            {
              "letter": "C",
              "text": "The anxiety and worry are associated with three (or more) of the following six symptoms:",
              "subCriteria": [
                {
                  "text": "1. Restlessness or feeling keyed up or on edge"
                },
                {
                  "text": "2. Being easily fatigued"
                },
                {
                  "text": "3. Difficulty concentrating or mind going blank"
                },
                {
                  "text": "4. Irritability"
                },
                {
                  "text": "5. Muscle tension"
                },
                {
                  "text": "6. Sleep disturbance"
                }
              ]
            }
          ]
        }
      },
      "quickView": {
        "definicao": "A disorder characterized by excessive and persistent anxiety and worry about various events or activities, which is difficult to control and is associated with physical and cognitive symptoms.",
        "criteriosDiagnosticos": [
          "Excessive worry on most days for ≥6 months",
          "Difficulty controlling worry",
          "3 or more symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance",
          "Significant impairment in functioning"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "CBT (Cognitive Behavioral Therapy) - gold standard",
            "Acceptance and Commitment Therapy (ACT)",
            "Mindfulness",
            "Relaxation techniques"
          ],
          "farmacologico": [
            "SSRIs: Escitalopram, Sertraline",
            "SNRIs: Venlafaxine XR",
            "Pregabalin (alternative)"
          ]
        },
        "redFlags": [
          "Suicidal ideation",
          "Severe comorbid anxiety disorders",
          "Treatment resistance",
          "Substance use"
        ],
        "examesIniciais": [
          "TSH (to rule out hyperthyroidism)",
          "Complete blood count",
          "GAD-7 scale for assessment"
        ]
      },
      "escalasAvaliacao": [
        {
          "name": "GAD-7",
          "description": "Generalized Anxiety Disorder-7: 7-item scale, score 0-21. ≥10 indicates moderate to severe GAD.",
          "cutoff": "≥10",
          "reference": "Spitzer et al., 2006"
        }
      ],
      "tags": [
        "anxiety",
        "gad",
        "ssris",
        "cbt",
        "dsm5",
        "mental_health"
      ]
    },
    {
      "id": "transtorno-panico",
      "titulo": "Panic Disorder",
      "categoria": "mental_health",
      "cid10": [
        "F41.0"
      ],
      "cid11": [
        "6B01"
      ],
      "ciap2": [
        "P74"
      ],
      "snomedCT": "371631005",
      "doid": "DOID:594",
      "meshId": "D016584",
      "umlsCui": "C0030319",
      "dsm5": {
        "code": "300.01",
        "category": "Anxiety Disorders",
        "diagnosticCriteria": {
          "code": "300.01",
          "name": "Panic Disorder",
          "category": "Anxiety Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Recurrent and unexpected panic attacks"
            },
            {
              "letter": "B",
              "text": "At least one of the attacks was followed by 1 month (or more) of one or both:",
              "subCriteria": [
                {
                  "text": "1. Persistent concern about additional attacks or their consequences"
                },
                {
                  "text": "2. Significant maladaptive behavioral change related to the attacks"
                }
              ]
            }
          ]
        }
      },
      "quickView": {
        "definicao": "Disorder characterized by recurrent and unexpected panic attacks, followed by persistent concern or significant maladaptive behavioral change.",
        "criteriosDiagnosticos": [
          "Recurrent and unexpected panic attacks",
          "At least 4 symptoms during the attack: palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, derealization, fear of losing control, fear of dying",
          "Persistent concern or behavioral change for ≥1 month"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Cognitive Behavioral Therapy with interoceptive exposure",
            "Psychoeducation about panic attacks",
            "Breathing techniques"
          ],
          "farmacologico": [
            "SSRIs: Sertraline, Paroxetine, Escitalopram",
            "Alprazolam (short-term use, avoid dependence)"
          ]
        },
        "redFlags": [
          "Severe agoraphobia",
          "Suicidal ideation",
          "Substance use",
          "Untreated comorbidity"
        ],
        "examesIniciais": [
          "ECG (to rule out arrhythmias)",
          "TSH",
          "Fasting glucose",
          "Complete blood count"
        ]
      },
      "tags": [
        "panic",
        "anxiety",
        "attacks",
        "ssris",
        "cbt",
        "dsm5"
      ]
    },
    {
      "id": "transtorno-bipolar-i",
      "titulo": "Bipolar I Disorder",
      "categoria": "mental_health",
      "cid10": [
        "F31"
      ],
      "cid11": [
        "6A60"
      ],
      "ciap2": [
        "P73"
      ],
      "snomedCT": "13746004",
      "doid": "DOID:3312",
      "meshId": "D001714",
      "umlsCui": "C0853193",
      "dsm5": {
        "code": "296.43",
        "category": "Bipolar and Related Disorders",
        "diagnosticCriteria": {
          "code": "296.43",
          "name": "Bipolar I Disorder",
          "category": "Bipolar and Related Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Criteria for a manic episode have been met"
            },
            {
              "letter": "B",
              "text": "The manic episode is not better explained by schizophrenia, schizoaffective disorder, or another psychotic disorder"
            }
          ]
        },
        "specifiers": {
          "severity": [
            "Mild",
            "Moderate",
            "Severe",
            "With Psychotic Features"
          ],
          "course": [
            "Single Manic Episode",
            "Most Recent Episode Manic",
            "Most Recent Episode Hypomanic",
            "Most Recent Episode Depressed",
            "Most Recent Episode Unspecified"
          ],
          "episode": [
            "With Catatonia",
            "With Peripartum Onset",
            "With Seasonal Pattern"
          ],
          "remission": [
            "In Partial Remission",
            "In Full Remission"
          ]
        }
      },
      "quickView": {
        "definicao": "Mood disorder characterized by at least one complete manic episode, often alternating with major depressive episodes.",
        "criteriosDiagnosticos": [
          "At least one manic episode (elevated/irritable mood + 3 symptoms for ≥1 week)",
          "Manic symptoms: grandiosity, reduced sleep, talkativeness, flight of ideas, distractibility, increased activity, involvement in risky activities",
          "Significant impairment or need for hospitalization"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Psychoeducation about the disorder",
            "Family therapy",
            "Social rhythm therapy"
          ],
          "farmacologico": [
            "Mood stabilizers: Lithium (gold standard)",
            "Anticonvulsants: Valproate, Carbamazepine",
            "Atypical antipsychotics: Quetiapine, Olanzapine"
          ]
        },
        "redFlags": [
          "Severe manic episode with psychosis",
          "Suicide risk during depression",
          "Non-adherence to treatment",
          "Recurrent episodes"
        ]
      },
      "criteriosEncaminhamento": [
        "First manic episode",
        "Severe manic episode or with psychosis",
        "Suicide risk",
        "Need for lithium adjustment",
        "Recurrent episodes despite treatment"
      ],
      "urgencia": {
        "riscosuicida": true,
        "riscoAgressao": true,
        "criterios": [
          "Severe manic episode",
          "Psychosis",
          "Risk of self-harm"
        ]
      },
      "tags": [
        "bipolar",
        "mania",
        "depression",
        "lithium",
        "stabilizers",
        "dsm5"
      ]
    },
    {
      "id": "transtorno-estresse-pos-traumatico",
      "titulo": "Post-Traumatic Stress Disorder (PTSD)",
      "categoria": "mental_health",
      "cid10": [
        "F43.1"
      ],
      "cid11": [
        "6B40"
      ],
      "ciap2": [
        "P74"
      ],
      "snomedCT": "47505003",
      "doid": "DOID:2055",
      "meshId": "D013313",
      "umlsCui": "C0038436",
      "dsm5": {
        "code": "309.81",
        "category": "Trauma- and Stressor-Related Disorders",
        "diagnosticCriteria": {
          "code": "309.81",
          "name": "Posttraumatic Stress Disorder",
          "category": "Trauma- and Stressor-Related Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Exposure to actual or threatened death, serious injury, or sexual violence"
            },
            {
              "letter": "B",
              "text": "Presence of one (or more) of the following intrusion symptoms:",
              "subCriteria": [
                {
                  "text": "1. Recurrent distressing memories"
                },
                {
                  "text": "2. Recurrent distressing dreams"
                },
                {
                  "text": "3. Dissociative reactions"
                },
                {
                  "text": "4. Intense psychological or physiological distress"
                }
              ]
            },
            {
              "letter": "C",
              "text": "Persistent avoidance of stimuli associated with the trauma"
            },
            {
              "letter": "D",
              "text": "Negative alterations in cognition and mood"
            },
            {
              "letter": "E",
              "text": "Marked alterations in arousal and reactivity"
            }
          ]
        }
      },
      "quickView": {
        "definicao": "A disorder that develops after exposure to a severe traumatic event, characterized by symptoms of intrusion, avoidance, negative cognitive/mood changes, and hyperarousal.",
        "criteriosDiagnosticos": [
          "Exposure to trauma (death, serious injury, violence)",
          "Intrusion symptoms: memories, dreams, flashbacks",
          "Persistent avoidance",
          "Negative cognitive/mood changes",
          "Hyperarousal and reactivity",
          "Duration >1 month"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Trauma-focused therapy (TF-CBT): EMDR, prolonged exposure therapy",
            "Cognitive-behavioral therapy with exposure",
            "Cognitive therapy for PTSD"
          ],
          "farmacologico": [
            "SSRIs: Sertraline, Paroxetine (FDA-approved)",
            "SNRIs: Venlafaxine",
            "Prazosin (for nightmares)"
          ]
        },
        "redFlags": [
          "Suicide risk",
          "Substance use",
          "Severe comorbidity",
          "Chronic PTSD unresponsive to treatment"
        ],
        "examesIniciais": [
          "Suicide risk assessment",
          "Substance use screening",
          "PCL-5 scale for evaluation"
        ]
      },
      "escalasAvaliacao": [
        {
          "name": "PCL-5",
          "description": "PTSD Checklist for DSM-5: 20-item scale, score 0-80. ≥33 indicates probable PTSD.",
          "cutoff": "≥33",
          "reference": "Weathers et al., 2013"
        }
      ],
      "tags": [
        "ptsd",
        "trauma",
        "stress",
        "emdr",
        "ssris",
        "dsm5"
      ]
    },
    {
      "id": "transtorno-distimico",
      "titulo": "Persistent Depressive Disorder (Dysthymia)",
      "categoria": "mental_health",
      "cid10": [
        "F34.1"
      ],
      "cid11": [
        "6A71"
      ],
      "ciap2": [
        "P76"
      ],
      "snomedCT": "78667006",
      "doid": "DOID:1596",
      "meshId": "D019263",
      "umlsCui": "C0013415",
      "dsm5": {
        "code": "300.4",
        "category": "Depressive Disorders",
        "diagnosticCriteria": {
          "code": "300.4",
          "name": "Persistent Depressive Disorder (Dysthymia)",
          "category": "Depressive Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Depressed mood for most of the day, for more days than not, as indicated by either subjective report or observation by others, for at least 2 years"
            },
            {
              "letter": "B",
              "text": "Presence, while depressed, of two (or more) of the following:",
              "subCriteria": [
                {
                  "text": "1. Decreased appetite or overeating"
                },
                {
                  "text": "2. Insomnia or hypersomnia"
                },
                {
                  "text": "3. Low energy or fatigue"
                },
                {
                  "text": "4. Low self-esteem"
                },
                {
                  "text": "5. Difficulty concentrating or making decisions"
                },
                {
                  "text": "6. Feelings of hopelessness"
                }
              ]
            }
          ]
        }
      },
      "quickView": {
        "definicao": "Chronic depressive disorder characterized by persistent depressed mood for ≥2 years, with less intense symptoms than MDD, but with significant functional impairment.",
        "criteriosDiagnosticos": [
          "Depressed mood for most of the day, ≥2 years",
          "≥2 symptoms: appetite, sleep, energy, self-esteem, concentration, hopelessness",
          "No symptom-free period >2 months",
          "Significant functional impairment"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Psychotherapy: CBT, IPT",
            "Behavioral activation",
            "Physical exercise"
          ],
          "farmacologico": [
            "SSRIs: Sertraline, Escitalopram",
            "SNRIs: Venlafaxine"
          ]
        },
        "redFlags": [
          "Superimposed MDD",
          "Suicidal ideation",
          "Treatment resistance"
        ],
        "examesIniciais": [
          "TSH",
          "PHQ-9"
        ]
      },
      "tags": [
        "dysthymia",
        "depression",
        "chronic",
        "ssris",
        "cbt",
        "dsm5"
      ]
    },
    {
      "id": "fobia-social",
      "titulo": "Social Phobia (Social Anxiety Disorder)",
      "categoria": "mental_health",
      "cid10": [
        "F40.1"
      ],
      "cid11": [
        "6B04"
      ],
      "ciap2": [
        "P74"
      ],
      "snomedCT": "25501002",
      "doid": "DOID:11257",
      "meshId": "D010698",
      "umlsCui": "C0031572",
      "dsm5": {
        "code": "300.23",
        "category": "Anxiety Disorders",
        "diagnosticCriteria": {
          "code": "300.23",
          "name": "Social Anxiety Disorder (Social Phobia)",
          "category": "Anxiety Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Marked fear or anxiety about one or more social situations in which the individual is exposed to possible scrutiny by others"
            },
            {
              "letter": "B",
              "text": "The individual fears that they will act in a way that shows symptoms of anxiety that will be negatively evaluated"
            },
            {
              "letter": "C",
              "text": "The social situations almost always provoke fear or anxiety"
            },
            {
              "letter": "D",
              "text": "The social situations are avoided or endured with intense fear or anxiety"
            }
          ]
        }
      },
      "quickView": {
        "definicao": "Anxiety disorder characterized by marked fear or anxiety in social situations where the individual is exposed to possible evaluation by others.",
        "criteriosDiagnosticos": [
          "Marked fear or anxiety in social situations",
          "Fear of being negatively evaluated",
          "Social situations almost always provoke fear/anxiety",
          "Avoidance or endurance with intense fear/anxiety",
          "Duration ≥6 months",
          "Significant functional impairment"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Cognitive Behavioral Therapy (CBT) with exposure - gold standard",
            "Social skills training",
            "Group therapy"
          ],
          "farmacologico": [
            "SSRIs: Paroxetine, Sertraline, Escitalopram",
            "SNRIs: Venlafaxine XR"
          ]
        },
        "redFlags": [
          "Severe avoidance with social isolation",
          "Comorbid depression",
          "Substance use to cope with situations"
        ],
        "examesIniciais": [
          "Functional assessment",
          "LSAS scale"
        ]
      },
      "escalasAvaliacao": [
        {
          "name": "LSAS",
          "description": "Liebowitz Social Anxiety Scale: 24-item scale to assess social phobia.",
          "reference": "Liebowitz, 1987"
        }
      ],
      "tags": [
        "social-phobia",
        "anxiety",
        "cbt",
        "ssris",
        "dsm5"
      ]
    },
    {
      "id": "anorexia-nervosa",
      "titulo": "Anorexia Nervosa",
      "categoria": "mental_health",
      "cid10": [
        "F50.0"
      ],
      "cid11": [
        "6B80"
      ],
      "ciap2": [
        "P99"
      ],
      "snomedCT": "56882008",
      "doid": "DOID:8689",
      "meshId": "D000856",
      "umlsCui": "C0003125",
      "dsm5": {
        "code": "307.1",
        "category": "Feeding and Eating Disorders",
        "diagnosticCriteria": {
          "code": "307.1",
          "name": "Anorexia Nervosa",
          "category": "Feeding and Eating Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Restriction of food intake leading to significantly low body weight"
            },
            {
              "letter": "B",
              "text": "Intense fear of gaining weight or becoming fat"
            },
            {
              "letter": "C",
              "text": "Disturbance in the way one experiences their weight or body shape"
            }
          ]
        }
      },
      "quickView": {
        "definicao": "Eating disorder characterized by food restriction, intense fear of gaining weight, and disturbance in weight/body perception, resulting in significantly low body weight.",
        "criteriosDiagnosticos": [
          "Food restriction → significantly low body weight (BMI <18.5 or weight <85% of expected)",
          "Intense fear of gaining weight",
          "Disturbance in weight/body perception",
          "Types: Restrictive or Binge Eating/Purging"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Multidisciplinary treatment: physician, nutritionist, psychologist",
            "Family therapy (for adolescents)",
            "Specialized cognitive-behavioral therapy",
            "Nutritional rehabilitation (supervised)"
          ],
          "farmacologico": [
            "Olanzapine (weight gain, obsessive symptoms)",
            "SSRIs for comorbidities (depression, anxiety)",
            "Nutritional supplementation if needed"
          ]
        },
        "redFlags": [
          "BMI <15 or rapid weight loss",
          "Bradycardia (<50 bpm)",
          "Orthostatic hypotension",
          "Hypothermia",
          "Amenorrhea",
          "Suicidal behavior"
        ],
        "examesIniciais": [
          "Weight, height, BMI",
          "Vital signs",
          "Complete blood count, electrolytes, liver and kidney function",
          "ECG (arrhythmias)",
          "Bone density (osteoporosis)"
        ]
      },
      "criteriosEncaminhamento": [
        "BMI <15",
        "Unstable vital signs",
        "Severe malnutrition",
        "Medical complications",
        "Failure of outpatient treatment"
      ],
      "urgencia": {
        "riscosuicida": true,
        "criterios": [
          "Severe malnutrition",
          "Unstable vital signs",
          "Medical complications"
        ]
      },
      "tags": [
        "anorexia",
        "eating",
        "restrictive",
        "olanzapine",
        "dsm5"
      ]
    },
    {
      "id": "bulimia-nervosa",
      "titulo": "Bulimia Nervosa",
      "categoria": "mental_health",
      "cid10": [
        "F50.2"
      ],
      "cid11": [
        "6B81"
      ],
      "ciap2": [
        "P99"
      ],
      "snomedCT": "78004001",
      "doid": "DOID:8513",
      "meshId": "D052018",
      "umlsCui": "C0006370",
      "dsm5": {
        "code": "307.51",
        "category": "Feeding and Eating Disorders",
        "diagnosticCriteria": {
          "code": "307.51",
          "name": "Bulimia Nervosa",
          "category": "Feeding and Eating Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Recurrent episodes of binge eating"
            },
            {
              "letter": "B",
              "text": "Recurrent inappropriate compensatory behaviors to prevent weight gain"
            },
            {
              "letter": "C",
              "text": "Episodes occur on average at least once a week for 3 months"
            }
          ]
        }
      },
      "quickView": {
        "definicao": "Eating disorder characterized by recurrent episodes of binge eating followed by inappropriate compensatory behaviors (self-induced vomiting, laxative use, excessive exercise).",
        "criteriosDiagnosticos": [
          "Recurrent episodes of binge eating (large amount in a short period, feeling of loss of control)",
          "Recurrent compensatory behaviors: self-induced vomiting, laxative/diuretic use, excessive exercise, fasting",
          "≥1 time/week for ≥3 months",
          "Self-evaluation unduly influenced by body shape and weight"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Specialized CBT (CBT-BN) - gold standard",
            "Interpersonal therapy (IPT)",
            "Nutritional psychoeducation"
          ],
          "farmacologico": [
            "SSRIs: Fluoxetine 60mg/day (approved for BN)",
            "Other SSRIs at high doses"
          ]
        },
        "redFlags": [
          "Severe electrolyte imbalance",
          "Esophagitis/tooth erosion",
          "Suicidal behavior",
          "Excessive laxative use"
        ],
        "examesIniciais": [
          "Electrolytes (hypokalemia, hyponatremia)",
          "Liver and kidney function",
          "Dental evaluation (erosion)"
        ]
      },
      "tags": [
        "bulimia",
        "binge",
        "purging",
        "fluoxetine",
        "cbt",
        "dsm5"
      ]
    },
    {
      "id": "transtorno-espectro-autista",
      "titulo": "Autism Spectrum Disorder (ASD)",
      "categoria": "mental_health",
      "cid10": [
        "F84.0"
      ],
      "cid11": [
        "6A02"
      ],
      "ciap2": [
        "P15"
      ],
      "snomedCT": "35919005",
      "doid": "DOID:0060041",
      "meshId": "D000067877",
      "umlsCui": "C1510586",
      "dsm5": {
        "code": "299.00",
        "category": "Neurodevelopmental Disorders",
        "diagnosticCriteria": {
          "code": "299.00",
          "name": "Autism Spectrum Disorder",
          "category": "Neurodevelopmental Disorders",
          "criteria": [
            {
              "letter": "A",
              "text": "Persistent deficits in social communication and social interaction across multiple contexts"
            },
            {
              "letter": "B",
              "text": "Restricted, repetitive patterns of behavior, interests, or activities"
            },
            {
              "letter": "C",
              "text": "Symptoms present in the early developmental period"
            }
          ],
          "specifiers": {
            "severity": [
              "Level 1 (Requires Support)",
              "Level 2 (Requires Substantial Support)",
              "Level 3 (Requires Very Substantial Support)"
            ]
          }
        }
      },
      "quickView": {
        "definicao": "A neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction, and restricted, repetitive patterns of behavior, present from early development.",
        "criteriosDiagnosticos": [
          "Deficits in social communication: socioemotional reciprocity, nonverbal communication, relationships",
          "Restricted/repetitive patterns: ≥2: stereotyped movements, insistence on routine, fixed interests, hyper/hyporeactivity to sensory input",
          "Symptoms present in early development (may not be evident until social demands exceed capabilities)",
          "Support level: 1 (mild), 2 (moderate), 3 (severe)"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Intensive early behavioral interventions",
            "Applied Behavior Analysis (ABA)",
            "Social communication therapy",
            "Occupational therapy (sensory integration)",
            "Specialized educational support"
          ],
          "farmacologico": [
            "Medication for specific symptoms:",
            "- Risperidone or Aripiprazole (aggression, irritability)",
            "- SSRIs for anxiety/obsessive behavior",
            "- Stimulants for comorbid ADHD"
          ]
        },
        "redFlags": [
          "Regression of skills",
          "Severe self-injurious behaviors",
          "Aggression",
          "Untreated psychiatric comorbidities"
        ],
        "examesIniciais": [
          "Multidisciplinary evaluation: pediatrician, neurologist, speech therapist, psychologist",
          "Auditory assessment (rule out hearing loss)",
          "Genetic testing (if indicated)",
          "Scales: ADOS, ADI-R"
        ]
      },
      "escalasAvaliacao": [
        {
          "name": "M-CHAT-R",
          "description": "Modified Checklist for Autism in Toddlers, Revised: Screening for ASD in children 16-30 months",
          "reference": "Robins et al., 2009"
        },
        {
          "name": "ADOS",
          "description": "Autism Diagnostic Observation Schedule: Gold standard for ASD diagnosis",
          "reference": "Lord et al., 2012"
        }
      ],
      "tags": [
        "autism",
        "ASD",
        "neurodevelopment",
        "ABA",
        "DSM-5"
      ]
    },
    {
      "id": "transtorno-uso-cannabis",
      "titulo": "Cannabis Use Disorder",
      "categoria": "mental_health",
      "cid10": [
        "F12"
      ],
      "cid11": [
        "6C41"
      ],
      "ciap2": [
        "P15",
        "P16"
      ],
      "snomedCT": "37344009",
      "doid": "DOID:0050742",
      "meshId": "D002189",
      "umlsCui": "C0006870",
      "dsm5": {
        "code": "304.30",
        "category": "Substance-Related and Addictive Disorders",
        "diagnosticCriteria": {
          "code": "304.30",
          "name": "Cannabis Use Disorder",
          "category": "Substance-Related and Addictive Disorders",
          "criteria": [
            {
              "text": "A pattern of problematic cannabis use leading to clinically significant impairment or distress, manifested by ≥2 criteria within 12 months"
            }
          ]
        }
      },
      "quickView": {
        "definicao": "A pattern of problematic cannabis use leading to clinically significant impairment or distress.",
        "criteriosDiagnosticos": [
          "≥2 criteria within 12 months: greater use than intended, efforts to reduce, excessive time spent, craving, failure to fulfill obligations, interpersonal problems, abandonment of activities, use in hazardous situations, continued use despite problems, tolerance, withdrawal"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Motivational Interviewing",
            "Cognitive Behavioral Therapy for Substance Use",
            "Contingency Management Therapy",
            "Support Groups"
          ],
          "farmacologico": [
            "Treatment of withdrawal symptoms if necessary",
            "Naltrexone may be helpful"
          ]
        },
        "redFlags": [
          "Psychotic disorder induced by cannabis",
          "Use in adolescents (higher risk of dependence)",
          "Comorbid psychiatric disorders"
        ],
        "examesIniciais": [
          "Toxicology test",
          "Evaluation of comorbid psychiatric conditions"
        ]
      },
      "tags": [
        "cannabis",
        "marijuana",
        "substance",
        "cognitive_behavioral_therapy",
        "dsm5"
      ]
    },
    {
      "id": "sindrome-ansiedade-generalizada",
      "titulo": "Generalized Anxiety Disorder",
      "ciap2": [
        "P74"
      ],
      "cid10": [
        "F41.1"
      ],
      "cid11": [
        "6B00"
      ],
      "categoria": "mental_health",
      "doid": "DOID:1596",
      "snomedCT": "48544008",
      "meshId": "D001008",
      "umlsCui": "C0003467",
      "hpo": [
        "HP:0000739"
      ],
      "tags": [
        "mental_health",
        "anxiety",
        "chronic"
      ],
      "quickView": {
        "definicao": "Excessive and persistent anxiety for ≥6 months. Difficult to control worries. Associated physical symptoms.",
        "criteriosDiagnosticos": [
          "Excessive anxiety for ≥6 months",
          "Difficulty controlling worries",
          "≥3 symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Cognitive Behavioral Therapy (CBT)",
            "Psychotherapy",
            "Relaxation techniques",
            "Exercise"
          ],
          "farmacologico": [
            "SSRIs: Sertraline or Escitalopram",
            "Benzodiazepines only for short-term use if necessary"
          ]
        },
        "redFlags": [
          "Suicidal ideation",
          "Panic attacks",
          "Psychiatric comorbidities"
        ]
      },
      "medicamentos": [
        "sertraline",
        "escitalopram"
      ],
      "protocolos": [],
      "calculadoras": []
    }
  ]
}